Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Nebulized combination ipratropium bromide with salbutamol
(D02147)		[2] Ipratropium,
Salbutamol		[1] Albuterol (D02147) 💬 [1] ADRB2 💬 [9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
2R-salbutamol
(D02147)		[2] Levosalbutamol,
Salbutamol		[2] Albuterol (D02147),
Levosalbutamol 💬 		[1] ADRB2 💬 [9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 49 💬
3R-salbutamol sulphate
(D02147)		[2] Levosalbutamol,
Salbutamol		[2] Albuterol (D02147),
Levosalbutamol 💬 		[1] ADRB2 💬 [9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 49 💬
4Salbutamol
(D02147)		[1] Salbutamol[1] Albuterol (D02147) 💬 [1] ADRB2 💬 [9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[8] 3, 11, 49, 85, 86, 111, 256, 299 💬
5Salbutamol (as Salbutamol Sulfate) 2 Mg Oral Tablet
(D02147)		[2] Salbutamol,
Sulfate ion		[1] Albuterol (D02147) 💬 [1] ADRB2 💬 [9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 111 💬
6Salbutamol 4Mg Tablet
(D02147)		[1] Salbutamol[1] Albuterol (D02147) 💬 [1] ADRB2 💬 [9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 11 💬
7Salbutamol Only Product in Oral Dose Form
(D02147)		[1] Salbutamol[1] Albuterol (D02147) 💬 [1] ADRB2 💬 [9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 111 💬
8SALBUTAMOL SULFATE
(D02147)		[2] Salbutamol,
Sulfate ion		[1] Albuterol (D02147) 💬 [1] ADRB2 💬 [9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 111 💬
9SALBUTAMOL SULFATE PH. EUR.
(D02147)		[2] Salbutamol,
Sulfate ion		[1] Albuterol (D02147) 💬 [1] ADRB2 💬 [9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 11 💬
10Salbutamol WZF 4 mg
(D02147)		[1] Salbutamol[1] Albuterol (D02147) 💬 [1] ADRB2 💬 [9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 11 💬
11Salbutamol-ratiopharm® N metered-dose aerosol inhaler
(D02147)		[1] Salbutamol[1] Albuterol (D02147) 💬 [1] ADRB2 💬 [9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 299 💬
12Salbutamol-ratiopharm® N metereddose aerosol inhaler
(D02147)		[1] Salbutamol[1] Albuterol (D02147) 💬 [1] ADRB2 💬 [9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 299 💬